Version 1
: Received: 27 February 2020 / Approved: 27 February 2020 / Online: 27 February 2020 (10:52:33 CET)
How to cite:
Anderson, G.; Maes, M. Sirtuins, Mitochondria and the Melatonergic Pathway in Alzheimer’s Disease. Preprints2020, 2020020396. https://doi.org/10.20944/preprints202002.0396.v1
Anderson, G.; Maes, M. Sirtuins, Mitochondria and the Melatonergic Pathway in Alzheimer’s Disease . Preprints 2020, 2020020396. https://doi.org/10.20944/preprints202002.0396.v1
Anderson, G.; Maes, M. Sirtuins, Mitochondria and the Melatonergic Pathway in Alzheimer’s Disease. Preprints2020, 2020020396. https://doi.org/10.20944/preprints202002.0396.v1
APA Style
Anderson, G., & Maes, M. (2020). Sirtuins, Mitochondria and the Melatonergic Pathway in Alzheimer’s Disease<strong> </strong>. Preprints. https://doi.org/10.20944/preprints202002.0396.v1
Chicago/Turabian Style
Anderson, G. and Michael Maes. 2020 "Sirtuins, Mitochondria and the Melatonergic Pathway in Alzheimer’s Disease<strong> </strong>" Preprints. https://doi.org/10.20944/preprints202002.0396.v1
Abstract
Alzheimer's disease (AD) has been the subject of extensive investigation as to its biological underpinnings. However, this has produced little of therapeutic benefit or indeed provided any accepted biomarkers that could tailor treatment. This chapter reviews data on the main pathophysiologic processes that have been widely shown to be altered in AD, including circadian dysregulation, mitochondrial dysfunction, gut dysbiosis, and immune-glia-platelet activation. It is proposed that alterations in the gut microbiome, including gut dysbiosis and increased gut permeability drive changes in mitochondrial function that are intimately associated with significant variations in sirtuin expression. Both mitochondria-located and nucleus/cytoplasm located sirtuins can act on mitochondrial function in different cells and body systems to co-ordinate the ageing-associated changes that underpin AD. The sirtuins are therefore key aspect to a developmental model of AD that is more 'holistic' in perspective, thereby providing a framework for the detection of earlier biomarkers and more successful treatment for the heterogenous nature of AD pathoetiology.
Medicine and Pharmacology, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.